Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
- 1 January 1995
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 36 (2) , 139-155
Abstract
Vascular endothelial growth factor (VEGF) / vascular permeability factor (VPS) plays a crucial role for the vascularization of tumors including breast cancers. Tumors produce ample amounts of VEGF, which stimulates the proliferation and migration of endothelial cells (ECs), thereby inducing tumor vascularization by a paracrine mechanism. VEGF receptors (VEGF-Rs) are highly expressed by the ECs in tumor blood vessels. VEGF expression can be induced in various cell types by a number of stimuli including hypoxia, differentiation, growth factors and tumor promoters of the phorbol ester class, such as TPA. The VEGF inductive pathways comprise kinases, oncogenes, tumor suppressor genes, and steroid hormone transcription factors, many of which seem to converge on the activator protein (AP-1) transcription factor. Much less is known about the regulation of VEGF-R expression, which is restricted to ECs. This expression is greatly enhanced in diseased tissue such as solid tumors. So far, it appears that growth factors, cytokines, and tumor promoters are involved in the control of VEGF-R expression. Here we review current knowledge about the regulation of the expression of VEGF and its receptors.Keywords
This publication has 124 references indexed in Scilit:
- Specificity of Vascular Endothelial Cell Growth Factor Receptor Ligand Binding DomainsBiochemical and Biophysical Research Communications, 1994
- Vasculotropin/Vascular Endothelial Growth Factor Induces Differentiation in Cultured OsteoblastsBiochemical and Biophysical Research Communications, 1994
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The effects of TGF-α and 17β-estradiol on polyphosphoinositide metabolism in MCF-7 breast cancer cellsBreast Cancer Research and Treatment, 1992
- 1-Butyryl-Glycerol: A novel angiogenesis factor secreted by differentiating adipocytesCell, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Inhibition of endothelial cell proliferation by type β-transforming growth factor: Interactions with acidic and basic fibroblast growth factorsBiochemical and Biophysical Research Communications, 1986